نتایج جستجو برای: meningococcal diseases

تعداد نتایج: 854302  

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009
Tom Sprong Tom Eirik Mollnes Chris Neeleman Dorine Swinkels Mihai G Netea Jos W M van der Meer Marcel van Deuren

BACKGROUND Systemic activation of complement during meningococcal disease is associated with severe disease and poor outcome. The exact mechanism of activation of complement is unknown but is important for future therapies aimed at modulating the complement system in this disease. METHODS We studied complement activation in a group of 22 patients, including 18 with meningococcal septic shock ...

2014
Carine P Hedari Rima W Khinkarly Ghassan S Dbaibo

Invasive meningococcal disease is a serious infection that occurs worldwide. It is caused by Neisseria meningitidis, of which six serogroups (A, B, C, W-135, X, and Y) are responsible for most infections. The case fatality rate of meningococcal disease remains high and can lead to significant sequelae. Vaccination remains the best strategy to prevent meningococcal disease. Polysaccharide vaccin...

Journal: :Clinical microbiology reviews 1989
M D Cooper E J Moticka

The genus Neisseria contains two species of clinical importance: Neisseria gonorrhoeae and Neisseria meningitidis. Although these two microorganisms are closely related genetically, the diseases they produce differ greatly. N. gonorrhoeae is the etiologic agent of gonorrhea, currently among the most common of the classical sexually transmitted diseases, whereas N. meningitidis is the causative ...

2017
Vanina Masson-Behar Hervé Jacquier Pascal Richette Jean-Marc Ziza Valérie Zeller Christophe Rioux Baptiste Coustet Philippe Dieudé Sébastien Ottaviani

Arthritis secondary to invasive meningococcemia is rare and has been described as a direct result of bacteremia or as immunoallergic-type arthritis, related to the immune complex. Only a few case series have been reported.This multicenter study aimed to describe the clinical characteristics and therapeutic outcomes of arthritis secondary to meningococcal infection.We performed a 5-year retrospe...

Journal: :Pediatrics 2015
Jessica R MacNeil Nancy Bennett Monica M Farley Lee H Harrison Ruth Lynfield Megin Nichols Sue Petit Arthur Reingold William Schaffner Ann Thomas Tracy Pondo Leonard W Mayer Thomas A Clark Amanda C Cohn

BACKGROUND The incidence of meningococcal disease is currently at historic lows in the United States; however, incidence remains highest among infants aged <1 year. With routine use of Haemophilus influenzae type b and pneumococcal vaccines in infants and children in the United States, Neisseria meningitidis remains an important cause of bacterial meningitis in young children. METHODS Data we...

Journal: :The Pediatric infectious disease journal 2012
Andrew Terranella Susan E Beekmann Philip M Polgreen Amanda Cohn Henry M Wu Thomas A Clark

BACKGROUND Although empiric treatment regimens for acute bacterial meningitis are well established, there are many uncertainties regarding management of meningococcal disease. A survey was conducted among infectious disease specialists to assess meningococcal disease practice patterns and availability of antimicrobial susceptibility testing for Neisseria menigitidis. METHODS An online survey ...

Journal: :Pediatrics 2015
Lucy A McNamara Alice M Shumate Peter Johnsen Jessica R MacNeil Manisha Patel Tina Bhavsar Amanda C Cohn Jill Dinitz-Sklar Jonathan Duffy Janet Finnie Denise Garon Robert Hary Fang Hu Hajime Kamiya Hye-Joo Kim John Kolligian Janet Neglia Judith Oakley Jacqueline Wagner Kathy Wagner Xin Wang Yon Yu Barbara Montana Christina Tan Robin Izzo Thomas A Clark

BACKGROUND In 2013-2014, an outbreak of serogroup B meningococcal disease occurred among persons linked to a New Jersey university (University A). In the absence of a licensed serogroup B meningococcal (MenB) vaccine in the United States, the Food and Drug Administration authorized use of an investigational MenB vaccine to control the outbreak. An investigation of the outbreak and response was ...

2010
Susu M. Zughaier Pavel Svoboda Jan Pohl David S. Stephens William M. Shafer

Capsular polysaccharides (CPS) are a major virulence factor in meningococcal infections and form the basis for serogroup designation and protective vaccines. Our work has identified meningococcal CPS as a pro-inflammatory ligand that functions through TLR2 and TLR4-MD2-dependent activation. We hypothesized that human cationic host defense peptides interact with CPS and influence its biologic ac...

Journal: :BMC Infectious Diseases 2006
Jiun-Ling Wang Ding-Ping Liu Jer-Jea Yen Chia-Jung Yu Hsi-Chen Liu Ching-Yuang Lin Shan-Chwen Chang

BACKGROUND Few published reports have evaluated the clinical features and outcome of serogroup W135 meningococcal disease. In Taiwan, W135 is the second most prevalent meningococcal disease serogroup. METHOD A nationwide study was conducted to retrospectively analyze epidemiologic data from 115 patients with laboratory confirmed meningococcal disease that occurred from 2001 through 2003. RE...

2017
Lloyd Steele Katie Bechman Eoghan De Barra Charles Mackworth-Young

BACKGROUND We report the first adult case of Neisseria meningitidis W-135 presenting with meningococcal arthritis and myopericarditis concomitantly, without other classical features of meningococcal disease. CASE PRESENTATION A 67-year-old Caucasian man presented with acute-onset polyarthralgia, myalgia, and fever. On examination he had polyarticular synovitis. An electrocardiogram (ECG) demo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید